Liminatus Pharma, Inc. — Investor Relations & Filings
Filings indexed
83
across all filing types
Latest filing
2026-05-27
Regulatory Filings
Country
US
United States of America
Listing
US
LIMN
Liminatus Pharma, Inc. is a pre-clinical-stage biopharmaceutical company focused on developing novel, immune-modulating cancer therapies. The company specializes in immuno-oncology and is pioneering the development of a second-generation CD47-blockade antibody. This therapeutic approach is designed to utilize the patient's immune system to target and destroy cancer cells. Its lead clinical candidate, IBA101, is a humanized anti-CD47 antibody being advanced toward clinical trials for the treatment of various cancers.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 8-K | 2026-05-27 | English | |
| FORM 8-K | 2026-05-20 | English | |
| 10-Q | 2026-05-15 | English | |
| 10-K - Liminatus Pharma, Inc. (0001971387) (Filer) | 2026-03-31 | English | |
| 8-K - LIMINATUS PHARMA, INC. (0001971387) (Filer) | 2026-03-04 | English | |
| 8-K Filing | 2026-02-18 | English |
Browse filings by year
4 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
10 filings
| |||||
| 47845366 | FORM 8-K | 2026-05-27 | English | ||
| 46693288 | FORM 8-K | 2026-05-20 | English | ||
| 46362206 | 10-Q | 2026-05-15 | English | ||
| 33122863 | 10-K - Liminatus Pharma, Inc. (0001971387) (Filer) | 2026-03-31 | English | ||
| 32900806 | 8-K - LIMINATUS PHARMA, INC. (0001971387) (Filer) | 2026-03-04 | English | ||
| 32267708 | 8-K Filing | 2026-02-18 | English | ||
| 32267649 | 424B4 Filing | 2026-02-18 | English | ||
| 32267778 | S-1 Filing | 2026-02-11 | English | ||
| 32267630 | 8-K Filing | 2026-02-09 | English | ||
| 13651327 | FORM 8-K | 2026-01-26 | English | ||
|
2025
5 filings
| |||||
| 13651348 | FORM 8-K | 2025-11-25 | English | ||
| 13651425 | 10-Q | 2025-11-14 | English | ||
| 13651432 | 10-Q | 2025-10-04 | English | ||
| 13651428 | FORM 8-K | 2025-08-25 | English | ||
| 13651426 | PRIMARY DOCUMENT | 2025-08-15 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BIOVIE INC.
Develops drug therapies for neurological disorders and adva…
|
BIVI | US | Manufacturing |
|
BioXcel Therapeutics, Inc.
Biopharmaceutical company using AI to develop drugs for neu…
|
BTAI | US | Manufacturing |
|
Bioxel Pharma Inc.
Develops, manufactures, and markets taxane APIs, essential …
|
— | CA | Manufacturing |
|
BIOXYNE LIMITED
Life sciences company focused on probiotics, medicinal cann…
|
BXN | AU | Manufacturing |
|
B&K CORPORATION LIMITED
Innovative biopharma developing PDGF therapeutic drugs for …
|
2396 | HK | Manufacturing |
|
Black Diamond Therapeutics, Inc.
Develops precision oncology therapies targeting families of…
|
BDTX | US | Manufacturing |
|
BLAU FARMACÊUTICA S.A.
Multinational producer of high-complexity medications for h…
|
— | BR | Manufacturing |
|
Bliss GVS Pharma Limited
Global leader in suppository and pessary production for eme…
|
BLISSGVS | IN | Manufacturing |
|
Blis Technologies Limited
Develops and commercializes patented probiotic strains for …
|
BLT | NZ | Manufacturing |
|
Bloomage Biotechnology Corporation Limited
Global leader in hyaluronic acid and bioactive substance re…
|
688363 | CN | Manufacturing |
Liminatus Pharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34636/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34636 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34636 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34636 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34636}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Liminatus Pharma, Inc. (id: 34636)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.